FindTrial
Sign In

PROVID-CAPSyS - Systems Medicine of COVID-19, extension Study on PROVID-PROGRESS

PROVID-CAPSyS - Systems Medicine of COVID-19, extension Study on PROVID-PROGRESS - PROVID-CAPSyS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023389
Enrollment
60
Registered
2021-01-29
Start date
2021-03-10
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 J13 J14 J15 J16 J17 J18

Interventions

Group 1: The PROVID-CAPSyS study will include adult hospitalized patients with SARS-CoV-2 infection / COVID-19 with severe course and ventilation. The PROVID-CAPSyS target of N=60 evaluable patients i

Sponsors

Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie und Arbeitsbereich pulmonale Inflammation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Positive detection of SARS-CoV-2-virus, ventilation (invasive, non-invasive, high-flow, ECMO), informed consent

Exclusion criteria

Exclusion criteria: Patient participation in PROVID-CAPNETZ, PROVID-PROGRESS or PROVID-CAPSyS at an earlier time, simultaneous participation in PROVID-CAPNETZ, pregnancy, breast feeding, active tuberculosis

Design outcomes

Primary

MeasureTime frame
death—

Secondary

MeasureTime frame
Length of hospitalization length of ICU treatment length of mechanical ventilation organ involvement (complications) long-term effects changes in quality of life—

Countries

Germany

Contacts

Public ContactAgata Mikolajewska

Charité - Universitätsmedizin BerlinMedizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie

agata.mikolajewska@charite.de+49 30 450 653559

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026